D. Gareth Evans

134.4k total citations · 21 hit papers
1.2k papers, 57.6k citations indexed

About

D. Gareth Evans is a scholar working on Genetics, Oncology and Neurology. According to data from OpenAlex, D. Gareth Evans has authored 1.2k papers receiving a total of 57.6k indexed citations (citations by other indexed papers that have themselves been cited), including 393 papers in Genetics, 290 papers in Oncology and 221 papers in Neurology. Recurrent topics in D. Gareth Evans's work include BRCA gene mutations in cancer (316 papers), Neurofibromatosis and Schwannoma Cases (215 papers) and Meningioma and schwannoma management (155 papers). D. Gareth Evans is often cited by papers focused on BRCA gene mutations in cancer (316 papers), Neurofibromatosis and Schwannoma Cases (215 papers) and Meningioma and schwannoma management (155 papers). D. Gareth Evans collaborates with scholars based in United Kingdom, United States and Germany. D. Gareth Evans's co-authors include Doyle J. Evans, David Y. Graham, Anthony Howell, David J. Evans, Fiona Lalloo, Susan Huson, Jillian M. Birch, Diana Eccles, Herbert L. DuPont and Peter Klein and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

D. Gareth Evans

1.1k papers receiving 54.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prophylactic Oophorectomy in Carriers ofBRCA1orBRCA2Mutations

2002 1.0k citations Timothy R. Rebbeck, Henry T. Lynch et al. profile →
Malignant peripheral nerve sheath tumours in neurofibromatosis 1

2002 834 citations D. Gareth Evans et al. Journal of Medical Genetics profile →
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)

2010 816 citations Malcolm G. Dunlop, D. Gareth Evans et al. profile →
Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

2004 812 citations Timothy R. Rebbeck, Tara M. Friebel et al. Journal of Clinical Oncology profile →
Epidemiology of Helicobacter pylori in an asymptomatic population in the United States

1991 786 citations D. Gareth Evans et al. profile →
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)

2005 765 citations Martin O. Leach, Caroline Boggis et al. profile →
Preparation of Fe₃O₄@SiO₂@Layered Double Hydroxide Core–Shell Microspheres for Magnetic Separation of Proteins

2011 731 citations D. Gareth Evans et al. profile →
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

2006 689 citations D. Gareth Evans, Diana Eccles et al. profile →
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1

2006 652 citations D. Gareth Evans et al. Journal of Medical Genetics profile →
Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register service

2010 643 citations D. Gareth Evans, Fiona Lalloo et al. profile →
Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans

1975 605 citations D. Gareth Evans et al. profile →
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

2015 579 citations Douglas F. Easton, D. Gareth Evans et al. profile →
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women

2010 577 citations Michelle Harvie, Mary Pegington et al. profile →
Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

2006 513 citations D. Gareth Evans, Diana Eccles et al. profile →
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles

2006 511 citations D. Gareth Evans, Diana Eccles et al. profile →
Hemagglutination of Human Group A Erythrocytes by Enterotoxigenic Escherichia coli Isolated from Adults with Diarrhea: Correlation with Colonization Factor

1977 485 citations D. Gareth Evans et al. profile →
A Clinical Study of Type 2 Neurofibromatosis

1992 475 citations D. Gareth Evans et al. profile →
Factors influencing the eradication of Helicobacter pylori with triple therapy

1992 455 citations D. Gareth Evans et al. profile →
New Surface-Associated Heat-Labile Colonization Factor Antigen (CFA/II) Produced by Enterotoxigenic Escherichia coli of Serogroups O6 and O8

1978 358 citations D. Gareth Evans et al. profile →
EANO guideline on the diagnosis and treatment of vestibular schwannoma

2019 230 citations D. Gareth Evans et al. profile →
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

2022 98 citations Susan M. Domchek, D. Gareth Evans et al. profile →

Peers

Countries citing papers authored by D. Gareth Evans

Since Specialization

Citations

This map shows the geographic impact of D. Gareth Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Gareth Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Gareth Evans more than expected).

Fields of papers citing papers by D. Gareth Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Gareth Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Gareth Evans. The network helps show where D. Gareth Evans may publish in the future.

Co-authorship network of co-authors of D. Gareth Evans

This figure shows the co-authorship network connecting the top 25 collaborators of D. Gareth Evans. A scholar is included among the top collaborators of D. Gareth Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Gareth Evans. D. Gareth Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Breast density prediction from low and standard dose mammograms using deep learning: effect of image resolution and model training approach on prediction quality 2024 ·Biomedical Physics & Engineering Express ·(unknown), Elaine F. Harkness, Alistair Mackenzie, D. Gareth Evans, Sacha J. Howell, Susan Astley	1
2	An app promoting weight gain prevention via healthy behaviours amongst young women with a family history of breast cancer: Acceptability and usability assessment 2024 ·Journal of Human Nutrition and Dietetics ·Mary Pegington, Rhiannon E Hawkes, Alan Davies, Julia Mueller, Sacha J. Howell, D. Gareth Evans, David French, Michelle Harvie	0
3	Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2 ‐related schwannomatosis 2023 ·Clinical Genetics ·Dorothy Halliday, (unknown), D. Gareth Evans	6
4	MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1 2023 ·Journal of Medical Genetics ·(unknown), Emma J. Crosbie, Emma R. Woodward, Fiona Lalloo, Robert D. Morgan, Neil Ryan, D. Gareth Evans	2
5	The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis 2023 ·Neuro-Oncology Advances ·(unknown), Abdurrahman I. Islim, Cathal John Hannan, (unknown), Charlotte Hammerbeck-Ward, Scott Rutherford, Simon Freeman, Simon Lloyd, Michel Kalamarides, Miriam J. Smith, Kevin N. Couper, Catherine McBain, Michael D. Jenkinson, David Brough, Andrew T. King, D. Gareth Evans, Omar Pathmanaban	5
6	Neuroanatomical correlates of working memory performance in Neurofibromatosis 1 2022 ·Cerebral Cortex Communications ·(unknown), Jonathan Green, (unknown), Gorana Pobric, JeYoung Jung, Grace Vassallo, D. Gareth Evans, Charlotte J. Stagg, Laura M. Parkes, Stavros Stivaros, Nils Muhlert, Shruti Garg	1
7	Dominant‐negative pathogenic variant BRIP1 c. 1045G >C is a high‐risk allele for non‐mucinous epithelial ovarian cancer: A case‐control study 2021 ·Clinical Genetics ·(unknown), Elke M. van Veen, Olivia Smith, (unknown), William G. Newman, Emma J. Crosbie, Richard J. Edmondson, Miriam J. Smith, D. Gareth Evans	4
8	Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries 2021 ·International Journal of Epidemiology ·Amber N. Hurson, Parichoy Pal Choudhury, Chi Gao, Anika Hüsing, Mikael Eriksson, Min Shi, Michael E. Jones, D. Gareth Evans, Roger L. Milne, Mia M. Gaudet, Celine M. Vachon, Daniel I. Chasman, Douglas F. Easton, Marjanka K. Schmidt, Peter Kraft, Montserrat García‐Closas, Nilanjan Chatterjee, (unknown)	43
9	Epithelial ovarian cancer risk: A review of the current genetic landscape 2019 ·Clinical Genetics ·(unknown), Emma J. Crosbie, Richard J. Edmondson, Miriam J. Smith, D. Gareth Evans	41
10	RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer 2017 ·Cancer Epidemiology Biomarkers & Prevention ·Anthony Howell, Linda Ashcroft, Lesley Fallowfield, Diana Eccles, Rosalind A. Eeles, Ann Ward, Adam R. Brentnall, Mitch Dowsett, Jack Cuzick, (unknown), Caroline Boggis, (unknown), Jamie C. Sergeant, Judith E. Adams, D. Gareth Evans	4
11	Breast Cancer Risk in Young Women in the National Breast Screening Programme: Implications for Applying NICE Guidelines for Additional Screening and Chemoprevention 2014 ·Cancer Prevention Research ·D. Gareth Evans, Adam R. Brentnall, Michelle Harvie, Sarah Dawe, Jamie C. Sergeant, Paula Stavrinos, Susan Astley, Mary Wilson, John Ainsworth, Jack Cuzick, Iain Buchan, Louise S. Donnelly, Anthony Howell	32
12	Assessing Individual Breast Cancer Risk within the U.K. National Health Service Breast Screening Program: A New Paradigm for Cancer Prevention 2012 ·Cancer Prevention Research ·D. Gareth Evans, Jane Warwick, Susan Astley, Paula Stavrinos, (unknown), Sarah Ingham, Helen McBurney, (unknown), Michelle Harvie, Mary Wilson, Ursula Beetles, Ruth Warren, Alan Hufton, Jamie C. Sergeant, William G. Newman, Iain Buchan, Jack Cuzick, Anthony Howell	93
13	Fine-Mapping CASP8 Risk Variants in Breast Cancer 2012 ·Cancer Epidemiology Biomarkers & Prevention ·Nicola J. Camp, Marina Parry, Stacey Knight, Ryan Abo, Graeme Elliott, (unknown), Sabapathy P. Balasubramanian, Malcolm Reed, Helen McBurney, Ayşe Latif, William G. Newman, Lisa Cannon‐Albright, D. Gareth Evans, Angela Cox	20
14	A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis 2011 ·Cancer Prevention Research ·John Burn, D. Timothy Bishop, Pamela Chapman, Faye Elliott, Lucio Bertario, Malcolm G. Dunlop, Diana Eccles, Anthony E. Ellis, D. Gareth Evans, Riccardo Fodde, Eamonn R. Maher, Gabriela Möslein, Hans F. A. Vasen, (unknown), Robin Phillips, Steffen Bülow, John C. Mathers	151
15	Impaired Tamoxifen Metabolism Reduces Survival in Familial Breast Cancer Patients 2008 ·Clinical Cancer Research ·William G. Newman, Kristen D. Hadfield, Ayşe Latif, Stephen A. Roberts, A Shenton, (unknown), Fiona Lalloo, Sacha J. Howell, D. Gareth Evans	88
16	Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study 2008 ·Journal of Clinical Oncology ·Noah D. Kauff, Susan M. Domchek, Tara M. Friebel, Mark E. Robson, Johanna Lee, Judy E. Garber, Claudine Isaacs, D. Gareth Evans, Henry T. Lynch, Rosalind A. Eeles, Susan L. Neuhausen, Mary B. Daly, Ellen Matloff, Joanne L. Blum, Paul Sabbatini, Richard R. Barakat, Clifford A. Hudis, Larry Norton, Kenneth Offit, Timothy R. Rebbeck	381
17	Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) 2005 ·Queensland's institutional digital repository (The University of Queensland) ·Martin O. Leach, (unknown), (unknown), William D. Foulkes, (unknown), D. Gareth Evans, Fiona J. Gilbert, Ingolf Griebsch, (unknown), Preminda Kessar, Sunil R. Lakhani, S. Moss	1
18	Mutation Scanning of the NF2 Gene: An Improved Service Based on Meta-PCR/Sequencing, Dosage Analysis, and Loss of Heterozygosity Analysis 2004 ·Genetic Testing ·Andrew J. Wallace, Christy J.W. Watson, (unknown), D. Gareth Evans, R Elles	28
19	Non-Uptake of Predictive Genetic Testing for BRCA1/2 among Relatives of Known Carriers: Attributes, Cancer Worry, and Barriers to Testing in a Multicenter Clinical Cohort 2004 ·Genetic Testing ·Claire Foster, D. Gareth Evans, Rosalind A. Eeles, Diana Eccles, S. Ashley, Lucy Brooks, T Cole, Jackie Cook, R Davidson, Helen Gregory, James Mackay, P. Morrison, Maggie Watson	56
20	Feeding infants of diabetic mothers 2002 ·Archives of Disease in Childhood ·D. Gareth Evans, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact